health news today obesity drugs glp-1 Alarming rise in weight loss drug overdoses GLP1 medicines now address weight
Description
In fact, one 2022 follow-up study showed that most weight lost on semaglutide was regained within a year of discontinuation
Weight change and risk of venous thromboembolism: the Troms study
Its important to know that compounded GLP-1 medications arent FDA-approved, and the FDA hasnt reviewed them for safety, quality, or how well they work
If you have suffered serious eye problems after using a GLP-1 drug, Schlesinger Law Offices may be able to help
95% CI [0.600.91]
Wen et al
